What went wrong in the natalizumab trials?
Langer-Gould
Annette
A
Department of Health Research & Policy, Stanford University School of Medicine, CA94305, USA.
Steinman
Lawrence
L
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D002986:Clinical Trials as Topic; D003951:Diagnostic Errors; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D009103:Multiple Sclerosis / Q000175:diagnosis*; D000069442:Natalizumab; D020258:Neurotoxicity Syndromes / Q000209:etiology*; D018579:Patient Selection
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab